UK regulator to continually monitor approved AI medical devices
The UK's medicines regulator will continually monitor AI-based medical devices after approval, accepting all 44 recommendations from a report on their approval. A full implementation plan is due by spring 2027.
By Bhanvi Satija LONDON, Oct 6 (Reuters) — AI-based medical devices will need constant monitoring even after they're approved for use, rather than a single pre-approval safety check, the head of the UK's medicines regulator said on Tuesday. The UK government will accept all 44 recommendations from a report on how such AI tools are approved, it said. com; +44 7920644259;)